Promoting Quality in Drug Manufacturing

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-09-02-2004, Volume 28, Issue 9

FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.

Related Content:

Process ValidationManufacturingQuality SystemsRegulatory WatchDevelopmentPharmaceutical Technology-09-02-2004
How New Regulations Are Impacting Pharmaceutical Manufacturing Facility Design
A Look at the Impact of Industry Trends on Sensor Technologies (INTERPHEX 2024)
Single-Use Technologies Reinforce Fluid-Handling Workflows (INTERPHEX 2024)